The US Food and Drug Administration’s (FDA) advisory panel recently withheld the approval for opioid candidate, Acurox, used in treating moderate to severe pain.   Acurox is an orally administered tablet containing oxycodone HCl as an active analgesic ingredient, niacin as an active ingredient in subtherapeutic amounts, and a unique combination of other ingredients.   The candidate has been ...